{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:50:12Z","timestamp":1779918612462,"version":"3.53.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS53468"],"award-info":[{"award-number":["NS53468"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS44687"],"award-info":[{"award-number":["NS44687"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA137488"],"award-info":[{"award-number":["CA137488"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007155","name":"Walter S. and Lucienne Driskill Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s11060-016-2175-0","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T06:35:15Z","timestamp":1467959715000},"page":"301-309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ferumoxytol-enhanced MRI differentiation of meningioma from dural metastases: a pilot study with immunohistochemical observations"],"prefix":"10.1007","volume":"129","author":[{"given":"Bronwyn E.","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall L.","family":"Woltjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Prola-Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Nesbit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seymur","family":"Gahramanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Neuwelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"key":"2175_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/jcbfm.2009.192","volume":"30","author":"JS Weinstein","year":"2010","unstructured":"Weinstein JS, Varallyay CG, Dosa E et al (2010) Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 30:15\u201335","journal-title":"J Cereb Blood Flow Metab"},{"key":"2175_CR2","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1161\/STROKEAHA.110.607994","volume":"42","author":"E Dosa","year":"2011","unstructured":"Dosa E, Tuladhar S, Muldoon LL, Hamilton BE, Rooney WD, Neuwelt EA (2011) MRI using ferumoxytol improves the visualization of central nervous system vascular malformations. Stroke 42:1581\u20131588","journal-title":"Stroke"},{"key":"2175_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/01.RES.79.4.631","volume":"79","author":"GJ Christ","year":"1996","unstructured":"Christ GJ, Spray DC, el-Sabban M, Moore LK, Brink PR (1996) Gap junctions in vascular tissues. Evaluating the role of intercellular communication in the modulation of vasomotor tone. Circ Res 79:631\u2013646","journal-title":"Circ Res"},{"key":"2175_CR4","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.ajpath.2012.07.033","volume":"181","author":"PH Domingues","year":"2012","unstructured":"Domingues PH, Teodosio C, Ortiz J et al (2012) Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas. Am J Pathol 181:1749\u20131761","journal-title":"Am J Pathol"},{"key":"2175_CR5","unstructured":"http:\/\/www.dailymed.nlm.nih.gov\/dailymed\/archives\/fdaDrugInfo.cfm?archiveid=9818\n                    \n                  . Accessed 26 Feb 2016"},{"key":"2175_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0720-048X(98)00083-7","volume":"31","author":"F Maiuri","year":"1999","unstructured":"Maiuri F, Iaconetta G, de Divitiis O, Cirillo S, Di Salle F, De Caro ML (1999) Intracranial meningiomas: correlations between MR imaging and histology. Eur J Radiol 31:69\u201375","journal-title":"Eur J Radiol"},{"key":"2175_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1365-2990.1992.tb00825.x","volume":"18","author":"L Bo","year":"1992","unstructured":"Bo L, Mork SJ, Nyland H (1992) An immunohistochemical study of mononuclear cells in meningiomas. Neuropathol Appl Neurobiol 18:548\u2013558","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2175_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3171\/jns.1979.50.3.0305","volume":"50","author":"RA Morantz","year":"1979","unstructured":"Morantz RA, Wood GW, Foster M, Clark M, Gollahon K (1979) Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. J Neurosurg 50:305\u2013311","journal-title":"J Neurosurg"},{"key":"2175_CR9","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1172\/JCI118997","volume":"98","author":"E Dejana","year":"1996","unstructured":"Dejana E (1996) Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 98:1949\u20131953","journal-title":"J Clin Invest"},{"key":"2175_CR10","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/jnen\/61.12.1048","volume":"61","author":"H Arishima","year":"2002","unstructured":"Arishima H, Sato K, Kubota T (2002) Immunohistochemical and ultrastructural study of gap junction proteins connexin26 and 43 in human arachnoid villi and meningeal tumors. J Neuropathol Exp Neurol 61:1048\u20131055","journal-title":"J Neuropathol Exp Neurol"},{"key":"2175_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3171\/jns.1970.32.2.0127","volume":"32","author":"DM Long","year":"1970","unstructured":"Long DM (1970) Capillary ultrastructure and the blood\u2013brain barrier in human malignant brain tumors. J Neurosurg 32:127\u2013144","journal-title":"J Neurosurg"},{"key":"2175_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3171\/jns.1973.38.4.0409","volume":"38","author":"DM Long","year":"1973","unstructured":"Long DM (1973) Vascular ultrastructure in human meningiomas and schwannomas. J Neurosurg 38:409\u2013419","journal-title":"J Neurosurg"},{"key":"2175_CR13","unstructured":"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm440138.htm\n                    \n                  . Accessed 3 March 2016"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2175-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-016-2175-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2175-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2175-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:21:42Z","timestamp":1589700102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-016-2175-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["2175"],"URL":"https:\/\/doi.org\/10.1007\/s11060-016-2175-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]},"assertion":[{"value":"21 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Dr. Neuwelt\u2019s studies involving ferumoxytol were entirely funded by the Veterans Administration and NIH research Grants, and the Walter S. and Lucienne Driskill Foundation. None of the authors have financial interests in ferumoxytol, or in its developer AMAG.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}